Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19,667,509
-
Total 13F shares
-
15,574,833
-
Share change
-
+608,265
-
Total reported value
-
$1,123,051,822
-
Put/Call ratio
-
83%
-
Price per share
-
$72.10
-
Number of holders
-
202
-
Value change
-
+$43,367,440
-
Number of buys
-
101
-
Number of sells
-
97
Institutional Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q2 2023
As of 30 Jun 2023,
LIGAND PHARMACEUTICALS INC - Common Stock (LGND) was held by
202 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,574,833 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, MACQUARIE GROUP LTD, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, VILLERE ST DENIS J & CO LLC, Stephens Investment Management Group LLC, Chicago Capital, LLC, and abrdn plc.
This page lists
202
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.